.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Spotlight

OncClub: Join the Chat on Trending Trials in Cancer
Complimentary print subscription for home or office delivery
In-person and virtual events just for HCPs
Lively expert panel discussions featuring peer-to-peer exchanges
Subscribe to our eNewsletter for breaking news and curated content

SpecialtySee All >

Breast Cancer
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gastrointestinal Cancer
Genitourinary Cancers
Gynecologic Oncology
Immuno-Oncology
Lung Cancer
Melanoma & Skin Cancer
Multiple Myeloma
Urothelial Cancer

Advertise
About OncLive
Editorial Board
CancerNetwork.com
CGTlive.com
CureToday.com
OncNursingNews.com
TargetedOnc.com
Contact Us
Privacy
Terms & Conditions
Do Not Sell My Information

2 Clarke Drive
Suite 100
Cranbury, NJ 08512

ASCO 2020: Updates in Prostate Cancer Treatment

EP. 1: PSMA-Targeted Imaging in Prostate Cancer

July 9th 2020

EP. 2: Conventional Versus PSMA Imaging in Prostate Cancer

July 9th 2020

EP. 3: Data for Metastatic Castration-Sensitive Prostate Cancer

July 9th 2020

EP. 4: Clinical Trials in the Community Setting for Prostate Cancer

July 9th 2020

EP. 5: FDA Approved Agents for Non-Metastatic CRPC

July 9th 2020

EP. 6: Overall Survival Data Presented at ASCO 2020 for nmCRPC

July 9th 2020

EP. 7: Differences Between AR-Targeted Therapy in Prostate Cancer

July 9th 2020

EP. 8: The CARD and PROfound Trials for Metastatic CRPC

July 9th 2020

EP. 9: Impact of Clinical Data on the Treatment of mCRPC

July 9th 2020

EP. 10: Genetic Testing in Metastatic CRPC

July 9th 2020

EP. 11: Radium-223 in Metastatic CRPC

July 9th 2020

EP. 12: Emerging Therapies for Advanced Prostate Cancer

July 9th 2020